EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Comparing Disease‐Free Survival (DFS) and Overall Survival (OS) Rates in Breast Cancer Patients: Axillary Lymph Node Dissection (ALND) Versus Sentinel Lymph Node Biopsy (SLNB)

Bahar Amiri iD, Mahta Mellat Ardakani, Ali Pajouhi iD, Atieh Akbari iD, Simin Farokhi iD, Mohammad Esmaeil Akbari iD, Samaneh Tahmasebi Ghorabi iD, Arian Karimi Rouzbahani iD, Mania Beiranvand iD

International Journal of Breast Cancer · 2026-01 · 2026 (1)

DOI: 10.1155/ijbc/5039446 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Breast Cancer, online erschienen am 26.06.2026. Verfasst von Bahar Amiri und 8 weiteren Autor:innen. Beteiligte Einrichtung: Student Research Committee, Faculty of Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran, lums.ac.ir. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Examining the survival rate in breast cancer patients serves as a metric for assessing and advancing various treatment modalities. In light of the significant incidence of breast cancer in Iran, this study is aimed at examining and comparing the disease‐free survival (DFS) and overall survival (OS) rates among breast cancer patients who underwent axillary lymph node dissection (ALND) and sentinel lymph node biopsy (SLNB). Patients and Methods This retrospective cohort research included 1071 patients at Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran, from 1991 to 2021. The recurrence and survival rates of patients undergoing ALND and SLNB in both groups were examined and evaluated. The data were analyzed using SPSS statistical software using descriptive statistical techniques (percentage, frequency, mean, and standard deviation), Kaplan–Meier analysis, and Cox regression tests. A significance threshold of 0.05 is used.

Results

The average OS among all patients was 18.08 ± 0.51. The average OS in the ALND group was 18.1 ± 0.53; in the SLNB group, it was 12.8 ± 0.39, which was insignificant ( p < 0.05). The average DFS among all patients was 17.13 ± 0.51. The average DFS in the ALND group was 16.95 ± 0.54; in the SLNB group, it was 11.96 ± 0.3; the difference was insignificant ( p = 0.11).

Conclusion

OS and DFS in the ALND group were higher than in the SLNB group, but they were not statistically significant.

Schlagwörter

Stichwörter der Autor:innen

ALNDSLNBbreast cancerdisease-free survivaloverall survival

Autor:innen und Institutionen

  • Student Research Committee, Faculty of Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran, lums.ac.ir.
  • Razi Herbal Medicines Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran, lums.ac.ir.
  • USERN Office, Lorestan University of Medical Sciences, Khorramabad, Iran, lums.ac.ir.
  • Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran, sbmu.ac.ir.
  • Surgery Education and Research Network (SERGN), Universal Scientific Education and Research Network (USERN), Lorestan University of Medical Sciences, Melbourne, Australia, lums.ac.ir.
  • Maxillofacial Surgery and Implantology and Biomaterial Research Foundation, Khorramabad, Iran.

ORCID-Profile: Bahar Amiri, Ali Pajouhi, Atieh Akbari, Simin Farokhi, Mohammad Esmaeil Akbari, Samaneh Tahmasebi Ghorabi, Arian Karimi Rouzbahani, Mania Beiranvand

Zitieren

APA

Amiri, B., Mellat Ardakani, M., Pajouhi, A., Akbari, A., Farokhi, S., Akbari, M. E., Tahmasebi Ghorabi, S., Karimi Rouzbahani, A., & Beiranvand, M. (2026). Comparing Disease‐Free Survival (DFS) and Overall Survival (OS) Rates in Breast Cancer Patients: Axillary Lymph Node Dissection (ALND) Versus Sentinel Lymph Node Biopsy (SLNB). International Journal of Breast Cancer, 2026(1). https://doi.org/10.1155/ijbc/5039446

Vancouver

Amiri B, Mellat Ardakani M, Pajouhi A, Akbari A, Farokhi S, Akbari ME, et al. Comparing Disease‐Free Survival (DFS) and Overall Survival (OS) Rates in Breast Cancer Patients: Axillary Lymph Node Dissection (ALND) Versus Sentinel Lymph Node Biopsy (SLNB). International Journal of Breast Cancer. 2026;2026(1). doi:10.1155/ijbc/5039446

BibTeX
@article{Amiri2026,
  author = {Amiri, Bahar and Mellat Ardakani, Mahta and Pajouhi, Ali and Akbari, Atieh and Farokhi, Simin and Akbari, Mohammad Esmaeil and Tahmasebi Ghorabi, Samaneh and Karimi Rouzbahani, Arian and Beiranvand, Mania},
  title = {Comparing Disease‐Free Survival (DFS) and Overall Survival (OS) Rates in Breast Cancer Patients: Axillary Lymph Node Dissection (ALND) Versus Sentinel Lymph Node Biopsy (SLNB)},
  journal = {International Journal of Breast Cancer},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/ijbc/5039446}
}
Kostenlos starten →